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Abstract
Background: Cephalosporins are a class of antibiotics that are active against many Gram-positive and some
Gram-negative bacteria. Beyond their antibacterial activity, they are reported to have various immunomodulatory
properties. It has been shown that they reduce the secretion of cytokines as well as influence the humoral and
cellular immune response.
In the field conditions antibiotics are frequently administered at the same time as vaccines in pigs and, in the
view of their potential immunomodulatory properties, it is important to examine their effect on the development
and persistence of the post-vaccinal immune response. Ceftiofur is a very popular veterinary medicine third-generation
cephalosporin with a broad spectrum of activity. It has been shown that it can inhibit cytokines secretion and in this
way can potentially affect host immune response. The influence of ceftiofur on the immune response has not yet been
investigated in pigs. In the present study we evaluated the influence of therapeutic doses of ceftiofur hydrochloride on
the post-vaccinal immune response after vaccination with two model vaccines (live and inactivated).
Methods: Seventy pigs were divided into five groups: control, unvaccinated (C), control vaccinated against swine
influenza (SI-V), control vaccinated against pseudorabies (PR-V), vaccinated against SI during ceftiofur administration (SI-
CEF) and vaccinated against PR during ceftiofur administration (PR-CEF). Pigs from SICEF and PR-CEF groups received
therapeutic dose of ceftiofur for five days. Pigs from SI-CEF, PR-CEF, SIV and PR-V groups were vaccinated against SI and
PR. Antibodies to PRV were determined with the use of blocking ELISA tests (IDEXX Laboratories, USA). Humoral
responses to SIV were assessed based on haemagglutination inhibition assay. T-cell response was analyzed with the
use of proliferation test. The concentrations of IFN- γ and IL-4 in culture supernatant were determined with the use of
ELISA kits Invitrogen Corporation, USA).
Results: The significant delay in the development of humoral response against pseudorabies virus (PRV) as well as a
significant suppression of production of antibodies against swine influenza virus (SIV) was found in pigs receiving ceftiofur
hydrochloride at the time of vaccination. The cellular immune response against PRV was also significantly affected by
ceftiofur. In contrast, there were no significant differences between vaccinated groups with regard to the T-cell response
against SIV.
From day 28 of study to day 70, the concentration of INF-γ in culture supernatants were significantly lower in group
treated with ceftiofur after restimulation with PRV. While, no significant differences were observed after restimulation of
PBMC with H3N2 SIV.
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Conclusions: The effect of an antibiotic therapy with ceftiofur hydrochloride on the humoral and cellular post-vaccinal
immune responses in pigs was investigated. Ceftiofur hydrochloride was given in therapeutic doses. The results of the
present study indicate that both, humoral and cell-mediated post-vaccinal immune responses can be modulated by
treatment with ceftiofur hydrochloride. The results of our study point out that caution should be taken when
administered this antibiotic during vaccination of pigs.
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Background
Cephalosporins are a class of antibacterial agents that are
active against many Gram-positive and some Gram-
negative bacteria [1–4]. Beyond their antibacterial activity,
cephalosporins are reported to have various immunomod-
ulatory properties [1, 2, 5–8]. It has been found that cepha-
losporins reduce the secretion of cytokines and affect
migration of neutrophils [1, 2, 9, 10]. The influence of vari-
ous cephalosporins on the humoral and cellular immune
response has been also reported [5–8, 10]. It has been
shown, that they may inhibit mitogen-induced transform-
ation depending on the antibiotic tested, dose and the kind
of mitogen used [5, 6, 10]. The effect of cephalosporins on
the antibody production was also depending on compound
and class of immunoglobulin tested [7, 8, 11, 12].
Because in some cases the antibiotics are administered
at the same time as vaccines (i.e., after introduction of
new pigs into a herd), it is important to investigate the
effect of various chemotherapeutics on the development
and persistence of the post-vaccinal immune response in
pigs [13].
Ceftiofur is a third-generation cephalosporin devel-
oped strictly for veterinary use [1–3]. It is quite popular
in veterinary medicine because of its pharmacodynamic
and pharmacokinetic properties and a broad spectrum
of activity against Gram-positive and Gram-negative
bacteria, including β-lactamase-producing strains and
anaerobes [4]. Like other cephalosporins, ceftiofur is
bactericidal in vitro, resulting from inhibition of cell wall
synthesis [14]. Ceftiofur has worldwide approvals for re-
spiratory disease in swine (associated with Streptococcus
suis, Salmonella cholerasuis, Actinobacillus pleuropneu-
moniae and Pasteurella multocida), ruminants and
horses and has also been approved for foot rot and me-
tritis infections in cattle [3, 15]. The recommended dos-
age regimen of ceftiofur for the treatment of swine
respiratory disease is 3–5 mg/kg body weight adminis-
tered intramuscularly once daily for 3–5 consecutive
days [4].
It has been shown previously that ceftiofur can inhibit
LPS-stimulated TNF-α, IL-1β and IL-6 secretion in
vitro via activation of the NF-κB and MAP-kinase path-
ways [1]. Similar results were observed during in vivo
studies conducted on mice [2]. These data indicate that
ceftiofur can affect host immune response. The influ-
ence of ceftiofur on the immune response in vivo is not
sufficiently explained to date and has not yet been in-
vestigated in pigs.
In view of the potential immunomodulatory properties
of the ceftiofur and its frequent use in pigs under field
conditions, this study evaluated the influence of thera-
peutic doses of ceftiofur hydrochloride on the post-
vaccinal immune response after vaccination with two
model vaccines (live and inactivated).
Material and methods
Animals
Seventy pigs were bought from high health status herd,
located in Lubelskie voivodeship in Poland. The owner
of the herd gave the permission for use pigs in this
study. The herd was seronegative for both SIV and PRV
based on the routine monitoring. Pigs were transported
to the animal facilities of the Polish National Veterinary
Research Institute two weeks before experiment (accli-
matisation period). All animals used in the experiment
were confirmed negative for the antibodies against
pseudorabies virus (PRV) and swine influenza virus
(SIV). Only pigs that not received any of antibiotics be-
fore study were involved in the experiment. During
study pigs of all groups did not receive any treatment
beyond ceftiofur (in the respective groups).
Pigs were divided into five groups: control, unvaccinated
(C, n = 10), control vaccinated against swine influenza (SI-
V, n = 15), control vaccinated against pseudorabies (PR-V,
n = 15), vaccinated against swine influenza during ceftiofur
administration SI-CEF (n = 15) and vaccinated against
pseudorabies during ceftiofur administration PR-CEF
(n = 15). Animals were housed at the animal facility of
National Veterinary Research Institute in independent
units - one unit for the each group. Feed and water
(without antibiotics) were offered ad libitum.
Animal use and handling protocols were approved by
Local Ethical Commission (University of Life Sciences in
Lublin, Poland, number: 28/2012).
Drug and vaccines
A commercial product containing ceftiofur hydrochlor-
ide was used (Ceftiocyl, Vetoquinol Biowet Sp. z o.o.).
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Two model vaccines were used for vaccination of pigs
1) vaccine against pseudorabies (Akipor 6.3, Merial,
France) - as a model of live vaccine and 2) vaccine against
swine influenza (GRIPOVAC, Merial, France) as a model
of inactivated vaccine.
Experimental design
Pigs from SI-CEF and PR-CEF groups received recom-
mended dose of ceftiofur (3 mg per kg body weight per
day, intramuscularly) for five days (day −1 to day 3).
Pigs from SI-CEF, PR-CEF, SI-V and PR-V groups were
vaccinated intramuscularly at 10 and 12 weeks of age
(0 and 14 day of study) with appropriate doses of vaccines
(2 ml of each vaccine). Pigs from group C received the
same dose of PBS.
Blood sampling was performed for the following indi-
cations: evaluation of antigen-specific T-cell proliferation
and evaluation of humoral response. Moreover the se-
cretion of cytokines by peripheral blood mononuclear
cells (PBMC) ex vivo was analysed. The blood samples
were taken on days: −1, 6, 9, 14, 28, 42, 56 and 70.
Humoral response
Antibodies to the glycoprotein B (gB) and gE antigen were
determined with the use of blocking ELISA tests (HerdChe-
k*Anti-PRVgB or HerdChek*Anti-PRVgp1, IDEXX Labora-
tories, USA), according to manufacturer’s recommendation.
Optical density (OD) was measured at 650 nm wavelength
(Multiskan RC, Labsystems, Finland). The presence or ab-
sence of specific antibodies was determined by calculating
the sample to negative ELISA (S/N) ratio (OD of test
serum/mean OD of negative reference serum). Samples
were considered to be positive for gB antigen if ELISA S/N
ratio was less or equal to 0.5, while for gE antigen if ELISA
S/N ratio was lower or equal to 0.6
Humoral responses to SIV hemagglutinin (H3) were
assessed based on haemagglutination inhibition (HI)
assay. The HI assay was performed according to the
standard procedure, using 0.5 % chicken erythrocytes
and 4HA units of strain H3N2 (A/Sw/Flanders/1/98).
All sera were tested in serial twofold dilutions, started
1:20. For estimates of the prevalence, titres ≥ 20 were
considered positive. For statistical analyses titres lower
than 20 were set to 0.
Cellular response
Lymphocyte proliferation assay
The proliferation assay was done at day −1, 6, 9, 14, 28,
42, 56 and 70 of study, as described previously [31]. The
cells were restimulated with 50 μl of medium containing
live PRV, strain NIA-3 (titer 106.0 TCID50/50 μl) or live
H3N2 SIV (A/Sw/Flanders/1/98, titer 106.3 TCID50/50 μl
and 256 hemagglutinin units). In control tubes the per-
ipheral blood mononuclear cells were mock-stimulated
or stimulated with 5 μg/ml of concanavalin (Con-A)
(viability control). All samples were analysed in tripli-
cate. The incorporated radioactivity was measured in an
ultra low background liquid scintillation counter (Quan-
tulus, PerkinElmer, USA). Proliferation was expressed as
a stimulation index (S-index) calculated as follows: the
number of counts per minute (cpm) for stimulated
PBMCs divided by the number of cpm for the unstimu-
lated control cells (mock-control).
Based on the S-index values observed at day −1 (be-
fore vaccination) and those observed in unvaccinated an-
imals (the mean value plus 3 x standard deviations), the
S-index equal or higher than 1.86 (PRV) or 3.66 (SIV)
was considered positive for antigen-specific proliferation.
Cytokines (IFN-γ, IL-4) secretion in vitro
The concentration of Th1 or Th2-type cytokines (IFN- γ
and IL-4) in culture supernatant after ex vivo re-
stimulation of PBMC with PRV and H3N2 SIV were de-
termined with the use of ELISA kits specific for porcine
IFN-γ and IL-4 (Invitrogen Corporation, USA). Un-
stimulated cells served as control (mock control).
PBMC were isolated and incubated (72 h) under the
same conditions as for proliferation test. In each experi-
ment, serial dilutions of swine IFN-γ and IL-4 standards
were tested to determine calibration curves, which were
then computer adjusted (with the use of the CurveEx-
pert software). Concentration of cytokines in superna-
tants was calculated using the same software.
Statistical analysis
A nonparametric Kruskal-Wallis test with post hoc mul-
tiple comparisons for comparison of all pairs was used
(STATISTICA 8.0; StatSoft). For all analyses p ≤ 0.05 was
considered significant.
Results
Humoral response against pseudorabies virus and H3N2
swine influenza virus
The development and persistence of antibodies specific
to gB of PRV and H3N2 SIV in animals from all groups
is presented on Fig. 1.
Before vaccination all pigs had no antibodies against
both gB and gE of PRV and against SIV. There were no
specific antibodies against gB of PRV and against SIV in
serum samples taken from unvaccinated pigs (group C).
Six days after the first vaccination in 5 out of 15 pigs
from group PR-V the specific humoral response at the
level considered positive was found (taking into consider-
ation the S/N ELISA ratio). At the same time none of the
pigs from PR-CEF group could be considered as positive.
Starting from day 9 after the first dose of vaccine the spe-
cific antibodies to gB of PRV at the level considered posi-
tive was observed in all vaccinated pigs, however in pigs
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received ceftiofur the level of antibodies was significantly
lower as compared to PR-V group (p < 0.05). The same is
also true with regard to the day 14 of study. From day 28
of study no significant differences were found between
ELISA S/N ratio in pigs from PR-CEF and PR-V group
(p > 0.05). In contrast significant differences were observed
between vaccinated and unvaccinated groups from day 6
of study to the end of experiment (p < 0.05).
None of the unvaccinated pigs had antibodies against
SIV at the end of the study. No seroconversion was ob-
served in vaccinated pig after the first vaccination (Fig. 1).
In general, antibody levels peaked 2 weeks after second
vaccination, after which they steadily decreased. From day
28 of study to day 56 the mean antihemagglutinin 3 (Anti-
HA3) antibody titer were significantly higher in pigs from
group SI-V (p < 0.05). Moreover, at day 70 of study, 7 out
of 15 pigs from SI-CEF group were seronegative to H3N2
SIV, while in group SI-V only 2 out of 15 animals had
Anti-HA3 antibody titer below 20.
Cellular response against pseudorabies virus and H3N2
swine influenza virus
The mean S-index values after vaccination against PRV
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Fig. 1 The development and persistence of antibodies specific to gB of pseudorabies virus (PRV) and H3N2 swine influenza virus (SIV). PR-V- pigs
vaccinated against pseudorabies, no treatment with antibiotic. PR-CEF - pigs received ceftiofur hydrochloride during vaccination against pseudorabies.
SI-V- pigs vaccinated against swine influenza, no treatment with antibiotic. SI-CEF - pigs received ceftiofur hydrochloride during vaccination against
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Fig. 2 The mean stimulation index values observed in pigs after vaccination against pseudorabies and swine influenza and in control, not
vaccinated animals. The bold lines indicate border-line between nonspecific and antigen-specific proliferation. PR-V- pigs vaccinated against
pseudorabies, no treatment with antibiotic. PR-CEF - pigs received ceftiofur hydrochloride during vaccination against pseudorabies. SI-V- pigs
vaccinated against swine influenza, no treatment with antibiotic. SI-CEF - pigs received ceftiofur hydrochloride during vaccination against
swine influenza. C - control pigs (unvaccinated, no antibiotic treatment). * - statistically significant differences between vaccinated groups
Pomorska-Mól et al. BMC Veterinary Research  (2015) 11:268 Page 4 of 8
are shown on Fig. 2. In unvaccinated group the SI
values ranged from 0.67 to 1.53 (for PRV) and from
1.14 to 2.91 (for SIV) during the period of study.
The PRV- specific proliferation was observed 6 days
after the first dose of vaccine in 9 out of 15 pigs from PR-
V group and in 3 out of 15 pigs from PR-CEF group. How-
ever, at this time-point no significant differences between
vaccinated and unvaccinated groups were observed with
regard to the mean value of S-index (p > 0.05). Starting
from day 9 of study the PRV-specific proliferation was ob-
served in all vaccinated pigs. The mean value of S-index
was significantly higher in pigs from PR-V group as com-
pared to pigs from PR-CEF from day 28 to the end of
study (p < 0.05).
No SIV-specific proliferation was observed in pigs be-
fore booster dose of vaccine. Two weeks after the second
dose of vaccine an antigen-specific proliferation was
found in each vaccinated pig. The mean value of S-index
did not differ significantly between vaccinated groups
(p > 0.05) during the period of study. However, starting
from day 28 of study (2 weeks after the second dose of
vaccine), the significant difference between S-index in
vaccinated and unvaccinated pigs was noted (p < 0.05).
Th1- and Th2-type cytokine secretion following in vitro
stimulation of PBMC
The summary of INF- γ analysis is shown in Fig. 3. The
mean constitutive production of INF-γ (without PRV or
H3N2 SIV stimulation) in experimental pigs did not ex-
ceed 9.91 pg/ml. After in vitro exposure to live PRV or
H3N2 SIV, naïve PBMC never secreted INF-γ higher
than 12.52 pg/ml and 13.78 pg/ml, respectively. In
unvaccinated group (C) there was no significant increase
of INF-γ concentration after PRV and H3N2 SIV restim-
ulation in all sampling points.
In contrast, in vitro PRV stimulation of PBMC from
vaccinated animals resulted in high amounts of INF-γ in
the culture supernatant. From day 28 of study to day 70,
the concentration of INF-γ in culture supernatants were
significantly higher in pigs from PR-V group as com-
pared with pigs from PR-CEF group. Significant differ-
ences between vaccinated and unvaccinated pigs were
observed from day 9 to the end of study (p < 0.05).
In contrast, no significant differences were observed
between groups vaccinated against swine influenza after
restimulation of PBMC with H3N2 SIV (p > 0.05).
However, in pigs from both vaccinated groups the sig-
nificantly higher production of INF- γ by PBMC was ob-
served after H3N2 SIV from day 28 to day 70 of study as
compared with control pigs (C)
In vitro stimulation with both viruses did not induce
measurable secretion of IL-4 by PBMC in the case of
both vaccinated and unvaccinated animals. In superna-
tants from stimulated and unstimulated cultures the
level IL-4 was undetectable (<15.6 pg/ml).
Discussion
The present study investigated the influence of ceftiofur
hydrochloride on the humoral and cellular post-vaccinal
immune response in pigs. The effect of simultaneous ad-
ministration of antibiotics and vaccines is frequently
underestimated when applying immunoprophylaxis pro-
grams in the field conditions. Without exact knowledge

















































day of study 
SI-V SI-CEF C
Fig. 3 Interferon-gamma (IFN-γ) secretion by peripheral blood mononuclear cells. The points represent the mean concentration of IFN-γ in culture
supernatant after stimulation with pseudorabies virus (PRV) or swine influenza virus (SIV). PR-V- pigs vaccinated against pseudorabies, no treatment
with antibiotic. PR-CEF - pigs received ceftiofur hydrochloride during vaccination against pseudorabies. SI-V- pigs vaccinated against swine influenza,
no treatment with antibiotic. SI-CEF - pigs received ceftiofur hydrochloride during vaccination against swine influenza. C - control pigs (unvaccinated,
no antibiotic treatment). * - statistically significant differences between vaccinated groups
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they are frequently applied at the time of vaccination. To
the authors best knowledge the effect of ceftiofur hydro-
chloride on the post-vaccinal response against pseudo-
rabies and swine influenza have not been previously
studied. In the present study, we have established that the
immune response produced with PRV and SIV vaccination
can be affected by the treatment with ceftiofur hydro-
chloride when applying at the same time as vaccines.
Various immunomodulatory properties have been re-
ported previously for several cephalosporins, including
ceftiofur [1, 2, 9, 10, 12, 16]. In the present study a delay
in the development of humoral response against PRV
was found in pigs receiving ceftiofur hydrochloride when
compared with PR-V group. The significant reduction in
ELISA S/N ratio against gB PRV antigen was observed
before the second dose of vaccine. It may suggest that
ceftiofur hydrochloride exert its effect mainly on the
IgM isotype. However, it is worth to mention that
antibody-response returned to normal level after the
boost. Moreover, a significant reduction in the develop-
ment of post-vaccinal Anti-HA3 antibody was noted in
pigs from SI-CEF group.
The influence of cephalosporins (cefotaxime,
cefodizime, ceftiofur sodium) on the humoral immunity
was also observed by others in various animal species
[1, 2, 9, 10, 12, 17]. Pulverer [16] reported that in
mice treated with therapeutic doses of cefotaxime, but
not with cefodizime, a remarkable and long-lasting in-
hibition of the IgM antibody production has been
found. Similar trends have been seen concerning the
IgG antibody response. In opposite, Borowski et al.
[12], reported that cephradine, in contrast to cefotax-
ime, suppressed the humoral response in mice in
doses corresponding to those used for the treatment
of patients. The results reported to date indicate that
various cephalosporins can produce different effects
on the immune response.
The marked reduction in the Anti-HA3 antibody titer
may be of great importance since Anti-HA antibody has
an important role in the protection against swine influ-
enza [18, 19]. In pigs vaccinated during antibiotic ther-
apy the mean HI titre were significantly lower than in
pigs not receiving ceftiofur. In addition, six weeks after
the second dose of vaccine all pigs from SI-V group had
HI titers exceeding the level commonly associated with
protective immunity against influenza (HI titre 40) [18].
In SI-CEF group only 7 out of 15 pigs had HI titre 40 at
that time. At the end of study the HI titers equal or over
40 were observed only in pigs from SI-V group. Vaccin-
ation of pigs against SIV is an important tool used to
prevent and control the disease in pigs. However, the re-
sults of our study indicate that administration of vaccine
during treatment with ceftiofur hydrochloride can have
a negative effect on the development and persistence of
post-vaccinal humoral immunity against SIV and in this
way affect the protection against infection.
Simultaneously to reduction of humoral response in
ceftiofur-treated pigs, no significant influence on the cellu-
lar immunity against SIV was observed in our investiga-
tion. In the current experiment the proliferation assay has
been used to evaluate the antigen-specific cellular immune
response [20–22]. A high level of proliferation in response
to antigen correlates with the expansion of antigen-
specific lymphocytes and indicates the superior anamnes-
tic responses of memory cells [23]. Moreover, IFN-γ pro-
duction has been reported to be a marker of cellular
immunity in some viral infections of pigs [20, 24].
Our results showed that, the vaccinated ceftiofur-
treated group had a significant decrease in IFN-γ pro-
duction above non-treated group after PRV stimulation.
Moreover, after PRV restimulation of PBMC isolated
from blood of pigs belonging to PR-CEF group the sig-
nificantly lower values of S-index were observed as com-
pared with PR-V group (p < 0.05). In contrast, no
significant differences in IFN-γ secretion were found
after stimulation of PBMC with H3N2 SIV. No signifi-
cant differences regarding S-index between SIV vacci-
nated groups were also noted.
The negative impact of ceftiofur hydrochloride on the
IFN-γ secretion after PRV restimulation can potentially
be important from a clinical point of view. It is well doc-
umented that cytokines secreted by T lymphocytes, play
a crucial role in the initiation and maintenance of anti-
viral immune responses [25]. The Th1-type immune re-
sponse is supposed to limit viral replication during
pseudorabies infection [25], thus lower production of
IFN-γ may be a sign of worst antiviral activity against
PRV. In contrast, during influenza infection, the cell-
mediated immunity plays a role mostly in the recovery
from influenza infection. It does not seem to contribute
notably in preventing infection [26]. The anti-HA anti-
body, the development and persistence of which were
negatively influenced by ceftiofur, are the most import-
ant in neutralizing the virus, and thus prevention of the
disease [26].
Ci et al. [2] have shown that pre-treatment with a dose
of ceftiofur that prevented death in mice, significantly de-
creases TNF-α, IL-6 and IL-1 production. The influence
of ceftiofur on the proportions among lymphocytes subset
in lymphatic organs has been also reported in chicks by
Chrząstek & Wieliczko [27]. The authors concluded that
treatment with ceftiofur might have an impact on the im-
mune response in chickens.
The mechanism of inhibition of T-cell response against
PRV by ceftiofur remains to be clarified. However the in-
fluence of ceftiofur on the production and secretion of
mediators of the immune response (i.e., cytokines) can be
considered as the probable reason [1, 2, 27, 28].
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The negative impact of other cephalosporins (cefotax-
ime) on T-cell immune response has been also reported
by Pulverer [16], who has found that cefotaxime induced
a significant and long-lasting inhibition of cellular im-
munity in mice. The same results have been also re-
ported by others [29, 30]. In contrast, no effects on the
cellular immunity were observed for cefodizime [16].
The significant suppression of in vitro lymphocyte
responses to the mitogens by various cephalosporins
(cephalexin, cephradine, cephalotin) has also been re-
ported [6]. Cephalexin and cephradine suppress lympho-
cyte response to PHA (phytohemagglutinin), ConA and
PWM (pokeweed mitogen), suggesting that these cepha-
losporins are probably acting by mechanism other than
a specific interference with mitogen binding cell mem-
brane [6]. In the study conducted by Borowski et al. [12]
the in vitro response of mouse splenocytes to PHA was
suppressed by cephradine and cephodizime, however
this occurred at therapeutic concentrations only in the
case of cephradine. Neither cephalosporin affected the
phagocytic and chemotactic activity of mouse peritoneal
macrophages and rabbit microphages [12].
Conclusion
In conclusion, the effect of an antibiotic therapy with
therapeutic doses of ceftiofur hydrochloride on the
humoral and cellular post-vaccinal immune responses in
pigs was investigated. The results of the present study
indicate that both, humoral and cell-mediated post-
vaccinal immune responses can be modulated by treat-
ment with therapeutic doses of ceftiofur hydrochloride.
However the impact of ceftiofur hydrochloride on the
humoral immunity seems to be related to the vaccine.
Because only one vaccine of each class has been use we
cannot exclude that the impact of ceftiofur hydrochlor-
ide may also depend on the vaccine. The results of our
study confirmed that caution should be taken when ad-
ministered this antibiotic during vaccination of pigs.
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